Last reviewed · How we verify

NCT07348926

The Relationship Between Functional Independence and Family Well-being in Children With Rare Genetic Disorders

Recruiting now Last updated 16 January 2026
What this trial tests

trial in Rare Genetic Disorders in 45 participants. Currently enrolling.

Timeline
25 October 2025
Primary endpoint
25 February 2026
15 March 2026

Quick facts

Lead sponsorBahçeşehir University
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment45
Start date25 October 2025
Primary completion25 February 2026
Estimated completion15 March 2026
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Bahçeşehir University

Who can join

Adults 18 to 65, any sex, with Rare Genetic Disorders or Quality of Life. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to examine the psychological status and quality of life of families with children who have rare genetic disorders. The focus of the study is to understand how the child's level of functional independence relates to the well-being of the family. Functional independence will be assessed using standardized tools, and parental psychological status and quality of life will be evaluated with validated questionnaires. The information gathered from this study may help improve the understanding of how rare genetic disorders affect family dynamics and daily functioning. The results may guide health care professionals in planning family-centered physiotherapy, psychological support, and care programs.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Bahçeşehir University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07348926.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing